2-(((5-hydroxy-4-oxo-4H-pyran-2-yl)methyl)thio)-3-(pyridin-2-yl)quinazolin-4(3H)-one

ID: ALA4786795

PubChem CID: 162667582

Max Phase: Preclinical

Molecular Formula: C19H13N3O4S

Molecular Weight: 379.40

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=c1cc(CSc2nc3ccccc3c(=O)n2-c2ccccn2)occ1O

Standard InChI:  InChI=1S/C19H13N3O4S/c23-15-9-12(26-10-16(15)24)11-27-19-21-14-6-2-1-5-13(14)18(25)22(19)17-7-3-4-8-20-17/h1-10,24H,11H2

Standard InChI Key:  IYRXJFQZLLOIDY-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   14.4686  -26.6742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4675  -27.4938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1755  -27.9027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1738  -26.2654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8824  -26.6706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8812  -27.4913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5874  -27.9003    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2993  -27.4933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3005  -26.6726    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.5897  -26.2591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5897  -25.4419    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.0059  -27.9039    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   18.7147  -27.4972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4213  -27.9078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4141  -28.7220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1166  -29.1324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8279  -28.7293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8321  -27.9112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1251  -27.4962    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.1120  -29.9472    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.5329  -29.1425    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.0073  -26.2687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7143  -26.6807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4225  -26.2745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4249  -25.4565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7132  -25.0463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0079  -25.4549    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
  8 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 16 20  2  0
 17 21  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
  9 22  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4786795

    ---

Associated Targets(non-human)

Tyr Tyrosinase (438 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
B16-F10 (4610 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 379.40Molecular Weight (Monoisotopic): 379.0627AlogP: 2.73#Rotatable Bonds: 4
Polar Surface Area: 98.22Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 8.70CX Basic pKa: 0.70CX LogP: 3.16CX LogD: 3.14
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.43Np Likeness Score: -1.29

References

1. Sepehri N,Iraji A,Yavari A,Asgari MS,Zamani S,Hosseini S,Bahadorikhalili S,Pirhadi S,Larijani B,Khoshneviszadeh M,Hamedifar H,Mahdavi M,Khoshneviszadeh M.  (2021)  The natural-based optimization of kojic acid conjugated to different thio-quinazolinones as potential anti-melanogenesis agents with tyrosinase inhibitory activity.,  36  [PMID:33640246] [10.1016/j.bmc.2021.116044]

Source